Formulation Development

Pharmaceutical formulation development is the critical step which links the discovery of a novel drug to commercialization. During this step, formulation scientists will determine the best drug delivery vehicle and dosage form needed to deliver a therapeutic effect based on bioavailability or other factors. Below you can explore articles, industry trends, and curated products which can help increase formulation development efficiency.

  • The Transformation of Drug Discovery

    More than five years have passed since COVID-19 was declared a global pandemic, marking the beginning of a healthcare crisis that has claimed millions of lives and continues to shape our world today. Early efforts to contain the elusive and ever-evolving SARS-CoV-2 virus demanded unprecedented collaboration among nations, healthcare systems, and ... read more

  • Introduction to the World of Artificial Intelligence

    Artificial Intelligence (AI) is no longer just a concept confined to the pages of science fiction or the minds of theoretical thinkers. It has grown into a transformative force that is reshaping industries, societies, and even the way we perceive reality. The rise of AI has Figure 1. Introduction to the World of Artificial Intelligence ... read more

  • Pharmaceutical P.I.N. Points: Patent Innovation News

    The purpose of this column is to highlight and summarize recent key patents in the pharmaceutical arena issued by the US Patent Office in March 2025. read more

  • Sharper, Faster, Smarter: The Mass Spectrometry Advantage in Bioanalytical Testing

    Drug-plasma protein binding is a fundamental parameter in drug development that directly affects how a compound is distributed, metabolized, and excreted. Only a drug’s unbound fraction is pharmacologically active, so accurate measurements are essential for understanding efficacy and safety. This information also guides dosage design, predicts ... read more

  • Spray Dried Dispersions in Controlled Release Formulations

    The pharmaceutical industry continues to face significant challenges in formulating poorly water-soluble drugs, which constitute most new chemical entities (NCEs).1 Among various solubility-enhancing strategies, amorphous solid dispersion (ASD) is one of the most effective and versatile strategies for enhancing oral bioavailability. ASDs can ... read more

  • Analytical Method Development with a Practical Risk Assessment Program that Enhances Commercial QC Robustness

    Active pharmaceutical ingredient process development requires comprehensive analytical controls utilizing a wide range of analytical methods. An analytical risk survey program was previously developed to evaluate common risk factors in the analytical control strategy for early to mid-stage development. For late-stage and the development of ... read more
Page
Page

Webinars

Page